RFM
MRNA icon

Royal Fund Management’s Moderna MRNA Stock Holding History

Royal Fund Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,800
Closed -$618K – 325
2024
Q1 		$618K Buy
+5,800
New +$585K 0.06% 229
2023
Q4 		– Sell
-3,200
Closed -$331K – 316
2023
Q3 		$331K Sell
3,200
-2,200
-41% -$245K 0.04% 226
2023
Q2 		$656K Buy
5,400
+1,700
+46% +$227K 0.08% 199
2023
Q1 		$568K Buy
+3,700
New +$610K 0.08% 198

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Royal Fund Management's MRNA Position: Q2 2024 in Review

Royal Fund Management sold out of Moderna (MRNA) in Q2 2024, closing a stake of 7,645 shares — an estimated $815K sold.

Royal Fund Management first reported a position in MRNA in Q1 2023 and held it in 5 quarters. The position peaked at $1.21M in Q3 2023. 954 funds tracked by Wall St. Rank hold MRNA as of Q2 2024.

  • Royal Fund Management reported no remaining Moderna position as of Q2 2024 after selling out during the quarter.
  • Royal Fund Management sold 7,645 Moderna shares in Q2 2024, an estimated $815K.
  • Royal Fund Management first reported a position in Moderna in Q1 2023 and held it in 5 quarters.
  • Royal Fund Management's Moderna position peaked at $1.21M in Q3 2023.
  • 954 funds tracked by Wall St. Rank held Moderna as of Q2 2024.

Based on Royal Fund Management's 13F filing for Q2 2024, filed 18 Jul 2024.